News

31 December, 2024

31 December, 2024

31 December, 2024

31 December, 2024

23 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

20 December, 2024

19 December, 2024

18 December, 2024

17 December, 2024

14 December, 2024

14 December, 2024

Pokaż więcej ↓

Pokaż mniej ↑

News

Recommendation of the President – HPV HR test with hrHPV genotyping including at least types 16 and 18

Recommendation of the President – Talzenna (talazoparib)

Recommendation of the President – Jardiance (empagliflozin)

Recommendation of the President – Lorenzo’s Oil

Recommendation of the President – Oxervate (cenegermin)

Publication AWA

Recommendation of the President – Renastep

Recommendation of the President – Vabinxo (valsartan + indapamide)

Recommendation of the President – Calcort (deflazacort)

Communication of the meeting of Transparency Council No. 52/2024 on 16 December 2024

Opinion of the Transparency Council – budesonideum

Position of the Transparency Council – flecainide

Position of the Transparency Council – Talzenna (talazoparib)

Position of the Transparency Council – HPV HR test with hrHPV

Position of the Transparency Council – Renastep

Position of the Transparency Council – Jardiance (empagliflozin)

Position of the Transparency Council – Jardiance (empagliflozin)

Position of the Transparency Council – Jardiance (empagliflozin)

Recommendation of the President – Chenodeoxycholic acid Leadiant (chenodeoxycholic acid)

Recommendation of the President on #HPP #48aa – Breast cancer prevention

Recommendation of the President – Proglicem (diazoxide)

The Transparency Council meeting 53/2024 on 23 December 2024

Status of work on December

Publication AWA